Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

Podcasts

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals More

Disease Activity

Response to: ‘Impact of Janus kinase inhibitors on the risk of cardiovascular events in patients with rheumatoid arthritis: systematic review and meta-analysis of randomised controlled trials’ by Lee and Song
Wenhui Xie, Shiyu Xiao, Zhuoli Zhang

Annals of the Rheumatic Diseases Jul 2019, annrheumdis-2019-215841; DOI: 10.1136/annrheumdis-2019-215841
Response to: ‘Concerns about the operational definition of remission in 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus’ by Rua-Figueroa and Erausquin
Antonis Fanouriakis, George Bertsias, Dimitrios T Boumpas

Annals of the Rheumatic Diseases Jul 2019, annrheumdis-2019-215810; DOI: 10.1136/annrheumdis-2019-215810
Response to: ‘Mycophenolate mofetil: a step forward in the induction treatment of ANCA-associated vasculitis? Comment on the article by Jones et al’ by Vandergheynst et al
Rachel B Jones, Thomas F Hiemstra, Michael Walsh, David Jayne, Lorraine Harper

Annals of the Rheumatic Diseases Jun 2019, annrheumdis-2019-215658; DOI: 10.1136/annrheumdis-2019-215658
Response to: ‘Alcohol is not the missing link between Porphyromonas gingivalis related periodontitis and radiologic progression in early Rheumatoid arthritis’ by Hillion et al
Hubert Marotte, Stéphane Paul

Annals of the Rheumatic Diseases Jun 2019, annrheumdis-2019-215731; DOI: 10.1136/annrheumdis-2019-215731
Sicca: an important manifestation of damage in systemic sclerosis (SSc) and SSc-overlap syndromes. Response to ‘Do the salivary glands of patients with systemic sclerosis show ultrasonographic modifications suggestive of Sjögren's syndrome?’ by Coudrec et al
Mandana Nikpour

Annals of the Rheumatic Diseases Jun 2019, annrheumdis-2019-215797; DOI: 10.1136/annrheumdis-2019-215797
Infrapatellar fat pad resection during total knee arthroplasty: yet another reason for?
Thomas J Ryan

Annals of the Rheumatic Diseases Jul 2019, 78 (7) e63; DOI: 10.1136/annrheumdis-2018-213684
Response to: ‘Serum complement factor C5a in IgG4-related disease’ by Fukui et al
Hisanori Umehara, Mitsuhiro Kawano

Annals of the Rheumatic Diseases Jul 2019, 78 (7) e66; DOI: 10.1136/annrheumdis-2018-213729
Serial IL-6 measurements in patients with tocilizumab-treated large-vessel vasculitis detect infections and may predict early relapses
Christoph T Berger, Birke Rebholz-Chaves, Mike Recher, Tobias Manigold, Thomas Daikeler

Annals of the Rheumatic Diseases Jul 2019, 78 (7) 1012-1014; DOI: 10.1136/annrheumdis-2018-214704
Chloroquine as alternative antimalarial in systemic lupus erythematosus: response to ‘2019 update of the EULAR recommendations for the management of SLE: don’t forget chloroquine’ by Figueroa-Parra et al
Antonis Fanouriakis, George K Bertsias, Dimitrios T Boumpas

Annals of the Rheumatic Diseases Jun 2019, annrheumdis-2019-215746; DOI: 10.1136/annrheumdis-2019-215746
Neutrophil extracellular traps and low-density granulocytes are associated with the interferon signature in systemic lupus erythematosus, but not in antiphospholipid syndrome
Lucas L van den Hoogen, Maarten van der Linden, Linde Meyaard, Ruth D E Fritsch-Stork, Joel A van Roon, Timothy RDJ Radstake

Annals of the Rheumatic Diseases Jun 2019, annrheumdis-2019-215781; DOI: 10.1136/annrheumdis-2019-215781

Pages